En Es
Categories

Industry News

Beckman Coulter Becomes First Diagnostics Company to Offer Workflow Automation Specifically for Mid-Volume Laboratories

By Labmedica International staff writers
05 May 2021

Image: DxA 5000 Fit (Photo courtesy of Beckman Coulter)Beckman Coulter (Brea, CA, USA) has announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day.

The clinical laboratory has gone through trial by fire in 2020, where total testing was 245% of baseline volumes, with ~55% being SARS-CoV-2 molecular tests. Despite vaccines, many industry players suggest SARS-CoV-2 testing volumes would not be impacted in the near term, and the demand for COVID-19-related testing will continue through 2021 and potentially into 2022. This means that testing-volume pressure on labs is going to continue.

Labs of all sizes are facing the same challenges: shortage of laboratory technologists and technicians, historic financial pressures on hospitals and health systems, and physically and mentally exhausted laboratory professionals - a pre-pandemic problem that has since been exacerbated. However, the TLA solutions that cater to labs processing high-sample volumes are out of reach for smaller volume labs due to space requirements and infrastructure constraints.

With the DxA 5000 Fit, mid-sized labs can enjoy the same benefits as larger-volume lab. The DxA 5000 Fit’s comprehensive workflow automation reduces up to 80% of manual steps through pre-analytical, analytical and post-analytical automation, thereby conserving precious human resources to do higher-value clinical work. It offers intelligent routing with dynamically calculated route planning for rapid and consistent TAT, with STATs always prioritized to deliver results faster. Additionally, its flexible design can be adapted to meet a mid-volume lab's space and infrastructure constraints.

"At Beckman Coulter, we believe that medium-size labs should be able to leverage the benefits of automation to address their challenges. Just because your lab is not processing a higher number of samples, doesn't mean you have to sacrifice the benefits of intelligent laboratory automation and settle for a marginally automated workcell-plus solution," said Dr. Peter Soltani, senior vice president & general manager, hematology, urinalysis & workflow information technology solutions at Beckman Coulter. "This is why we have launched DxA 5000 Fit, the first compact workflow automation solution that's the right fit for mid-volume labs because automation should be for all labs."




E-mail Print
FaceBook Twitter Google+ Linked in

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, electrochemistry, immunoassay, hematology and spectrophotometry products among others. The company’s biomedical laboratory instruments and diagnostic solutions, as well as automated and integrated data management systems, are suitable for diagnosing diseases, making treatment decisions and monitoring patients in hospitals and other critical care settings.
More info

More articles about BECKMAN COULTER, INC.

01 Feb 2021
Beckman Coulter Launches New DxH 560 AL Tabletop Hematology Analyzer for Small- and Medium-Sized Labs
Beckman Coulter (Brea, CA, USA) has launched the new DxH 560 AL, a tabletop hematology analyzer geared to reduce the time and resource constraints faced by small to mid-sized laboratories.
Read More
20 May 2019
Beckman Coulter Introduces New Total Laboratory Automation Solution
Beckman Coulter’s latest addition to its automation portfolio, the DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval.
Read More
01 Mar 2019
Beckman Coulter Life Sciences Enters Partnership with Apostle
Beckman Coulter Life Sciences has entered into a partnership with Apostle Inc. for the launch of Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit, a magnetic nanoparticle-based kit to extract circulating free DNA (cfDNA) from plasma using manual or automated workflows.
Read More
23 Jan 2019
Beckman Coulter Launches ClearLLab 10C System for Clinical Flow Cytometry Labs
Beckman Coulter has launched the ClearLLab 10C System for clinical flow cytometry labs that includes the first 10-color CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages.
Read More

Additional news

15 Jun 2021
Quidel Receives Amended FDA Emergency Use Authorization for New AI-Powered Sofia Q Rapid Antigen Test Device
Quidel Corporation (San Diego, CA, USA) has received an amended Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) allowing the company to market Sofia Q, its latest addition to the Sofia and Sofia 2 line of Fluorescent Immunoassay Analyzers (FIA).
Read More
15 Jun 2021
Global PET-CT Scanner Device Market to Reach USD 3.34 Billion by 2028
The global PET-CT scanner device market size is expected to register a CAGR of 6.6% from 2021 to 2028 to reach USD 3.34 billion by 2028, driven primarily by the increasing need to overcome the shortfalls of CT and PET in oncology imaging.
Read More
11 Jun 2021
Global Clinical Chemistry Analyzers Market to Reach USD 15.97 Billion by 2028
The global clinical chemistry analyzers market is projected to grow at a CAGR of 4.25% from USD 11.45 billion in 2020 to USD 15.97 billion by 2028, driven by growth in technology, rising global population, technological improvements in point of care testing devices, and development of laboratory automation.
Read More
09 Jun 2021
Global COVID-19 Saliva Screening Test Market to Reach USD 3,406.2 Billion by 2023
The global COVID-19 saliva screening test potential market size is expected to expand at a CAGR of 4.8% from USD 2955.9 billion in 2021 to USD 3,406.2 billion by 2023, driven by a rise in the demand for rapid, efficient, saliva-based screening tests.
Read More
20 May 2021
Global Lateral Flow Assays Market to Reach USD 13.85 Billion by 2027 Due to Benefits of Rapid Tests and Growing Demand for POC Testing
The global lateral flow assays market is expected to grow at a CAGR of 8.8% from 2020 to 2027 to reach USD 13.85 billion by 2027, driven mainly by the benefits of LFA-based rapid tests over laboratory testing and growing demand for point-of-care testing.
Read More
18 May 2021
PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems
PerkinElmer, Inc. (Waltham, MA; USA) and Immunodiagnostic Systems Holdings PLC (IDS; Boldon, Tyne and Wear, UK) have reached an agreement whereby PerkinElmer will acquire IDS for approximately USD 155 million.
Read More
14 May 2021
Siemens Launches its Fastest, Single-Source CT Scanner, Somatom X.ceed
Siemens Healthineers (Erlangen, Germany) has launched Somatom X.ceed, a new high-resolution, high-speed CT (computed tomography) scanner engineered specifically for the most challenging clinical areas where time and precision are of essence.
Read More
14 May 2021
Carestream Unveils Groundbreaking AI-Based Technology that Advances X-Ray Image Quality
Carestream Health (Rochester, N.Y., USA) has released Smart Noise Cancellation (SNC), a groundbreaking artificial intelligence (AI)-based technology that greatly improves image quality - producing images that are significantly clearer than with standard processing.
Read More
12 May 2021
Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions